|
⚲
|
| Keyboard |
| Sands Capital Alternatives LLC
✚
|
|
|---|---|
| CRD # | 155517 |
| SEC # | 801-72115 |
| CIK # | 0001846444 |
| AUM | 5,405.4 M (2026-03-30) |
| Employees | 182 (36% Investors, 0% Brokers) |
| Phone | 703-562-4000 |
| Address | 1000 Wilson Boulevard Arlington, VA 22209 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Nvidia Corp | 3.2 | ||
| Taiwan Semiconductor Manufacturing Co Ltd | 2.0 | ||
| Alphabet Inc | 1.5 | ||
| Amazon Com Inc | 1.4 | ||
| Shopify Inc | 1.1 | ||
| Netflix Inc | 0.9 | ||
| Spotify Technology Sa | 0.9 | ||
| ASML Holding NV | 0.8 | ||
| Visa Inc | 0.8 | ||
| MercadoLibre Inc | 0.8 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Sands Capital Global Innovation Fund II-FG LP | [2026-03-30] | 7.0 M | |
| Filed 2025-04-30 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Sands Capital Global Innovation Fund III-2 LP | [2026-03-30] | 556.4 M | |
| Filed 2025-05-19 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Sands Capital Global Innovation Fund III LP | [2026-03-30] | 973.5 M | 164.9 M |
| Filed 2026-01-28 (D/A) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Sands Capital Global Innovation Fund III-RP LP | [2026-03-30] | 20.0 M | 62.9 M |
| Filed 2025-05-02 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Sands Capital Global Innovation Fund III-X LP | [2026-03-30] | 163.2 M | |
| Filed 2025-05-19 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Sands Capital Global Innovation Fund II-An LP | [2025-03-31] | 119.4 M | |
| Filed 2024-06-25 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Sands Capital Global Innovation Fund II-DB LP | [2025-03-31] | 154.9 M | |
| Filed 2024-12-12 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Sands Capital Global Venture Fund II-Pa LP | [2025-03-31] | 4.4 M | |
| Filed 2024-03-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Sands Capital Global Venture Fund II-SLX LP | [2025-03-31] | ||
| Filed 2024-03-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Sands Capital Global Innovation Fund II-X LP | 2024-03-27 | 62.5 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 34 | 5.2 |
| (g) Pension and profit sharing plans | 0 | 0.2 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 37 | 5.4 |
| By Discretionary | ||
| Discretionary | 37 | 5.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 37 | 5.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 2.7 | |
| United States Persons | 2.8 | |
| Total | 37 | 5.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Jonathan Goodman | Executive Officer | 78 | 4 | |
| Michael Clarke | Executive Officer | 51 | 3 | |
| Michael Rubin | Executive Officer | 42 | 3 | |
| Erin Soule | Executive Officer | 55 | 2 | |
| Ian Ratcliffe | Executive Officer | 45 | 2 | |
| Barron Martin | Executive Officer | 22 | 2 | |
| Stephen Zachary | Executive Officer | 14 | 2 | |
| Michael Graninger | Executive Officer | 11 | 2 | |
| Scott Frederick | Executive Officer | 11 | 2 | |
| Job Taylor | Executive Officer | 4 | 2 | |
| Rubin Michael | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001846444] | |
| 13F-NT | [0001846444] | |
| 3 | [0001846444] | |
| 4 | [0001846444] | |
| SC 13G | [0001846444] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Sands Capital Ventures LLC | Klaviyo Inc | [2024-02-13] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.0B |
| Serves | Institutional |
| Fund Types | Private Equity |
| LEI | 254900IDJSY5RN37GV63 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sands Capital Life Sciences Pulse Fund II LP | |
| Sands Capital Alternatives LLC | |
| Sands Frank M | |
| Inhibikase Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Inhibikase Therapeutics Inc IKT
Common Stock
|
2025-11-21 | Buy | 2,068,965 | $1.45 | 2,999,999 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Integrum Holdings LP
✚
|
NY | 5,485.3 M |
|
QIC Investments No 1 PTY Ltd
✚
|
5,483.3 M | |
|
Bansk Group LLC
✚
|
NY | 5,475.5 M |
|
Monomoy Capital Management LP
✚
|
CT | 5,456.7 M |
|
Motive Capital Management LLC
✚
|
NY | 5,424.8 M |
|
Tailwind Management LP
✚
|
NY | 5,410.7 M |
|
Bain Capital Insurance Solutions LP
✚
|
MA | 5,393.2 M |
|
Cornell Capital LLC
✚
|
NY | 5,380.8 M |
|
Cove Hill Partners LP
✚
|
MA | 5,355.7 M |
|
Flexstone Partners LLC
✚
|
NY | 5,303.8 M |